BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15841082)

  • 1. Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid.
    Máximo V; Botelho T; Capela J; Soares P; Lima J; Taveira A; Amaro T; Barbosa AP; Preto A; Harach HR; Williams D; Sobrinho-Simões M
    Br J Cancer; 2005 May; 92(10):1892-8. PubMed ID: 15841082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point mutation in GRIM-19: a new genetic lesion in Hurthle cell thyroid carcinomas.
    Fusco A; Viglietto G; Santoro M
    Br J Cancer; 2005 May; 92(10):1817-8. PubMed ID: 15900303
    [No Abstract]   [Full Text] [Related]  

  • 3. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors.
    Máximo V; Soares P; Lima J; Cameselle-Teijeiro J; Sobrinho-Simões M
    Am J Pathol; 2002 May; 160(5):1857-65. PubMed ID: 12000737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hürthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance.
    Máximo V; Sobrinho-Simões M
    Virchows Arch; 2000 Aug; 437(2):107-15. PubMed ID: 10993269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid Hürthle cell tumors: research of potential markers of malignancy.
    Donatini G; Beaulieu A; Castagnet M; Kraimps JL; Levillain P; Fromont G
    J Endocrinol Invest; 2016 Feb; 39(2):153-8. PubMed ID: 26188382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RET/PTC rearrangement is prevalent in follicular Hürthle cell carcinomas.
    de Vries MM; Celestino R; Castro P; Eloy C; Máximo V; van der Wal JE; Plukker JT; Links TP; Hofstra RM; Sobrinho-Simões M; Soares P
    Histopathology; 2012 Nov; 61(5):833-43. PubMed ID: 22803838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of the BRAF and the GRIM-19 mutations in oncocytic (Hürthle cell) solid cell nests of the thyroid.
    Cameselle-Teijeiro J; Ferreira R; Caramés N; Abdulkader I; Máximo V; Soares P; Sobrinho-Simões M
    Am J Clin Pathol; 2012 Apr; 137(4):612-8. PubMed ID: 22431538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GRIM-19 in Health and Disease.
    Máximo V; Lima J; Soares P; Silva A; Bento I; Sobrinho-Simões M
    Adv Anat Pathol; 2008 Jan; 15(1):46-53. PubMed ID: 18156812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathology of well-differentiated thyroid carcinomas.
    Sobrinho-Simões M; Preto A; Rocha AS; Castro P; Máximo V; Fonseca E; Soares P
    Virchows Arch; 2005 Nov; 447(5):787-93. PubMed ID: 16189702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of EZH1 mutations in the diagnosis of follicular-patterned thyroid tumors.
    Jung CK; Kim Y; Jeon S; Jo K; Lee S; Bae JS
    Hum Pathol; 2018 Nov; 81():9-17. PubMed ID: 29723601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of alternatively spliced GRIM-19 mRNA in kidney cancer tissues.
    He X; Cao X
    J Hum Genet; 2010 Aug; 55(8):507-11. PubMed ID: 20505682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel germline variants identified in the inner mitochondrial membrane transporter TIMM44 and their role in predisposition to oncocytic thyroid carcinomas.
    Bonora E; Evangelisti C; Bonichon F; Tallini G; Romeo G
    Br J Cancer; 2006 Dec; 95(11):1529-36. PubMed ID: 17088905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solitary, multiple, and familial oxyphil tumours of the thyroid gland.
    Katoh R; Harach HR; Williams ED
    J Pathol; 1998 Nov; 186(3):292-9. PubMed ID: 10211119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activating BRAF Mutations Detected in Mixed Hürthle Cell Carcinoma and Multifocal Papillary Carcinoma of the Thyroid Gland: Report of an Unusual Case and Review of the Literature.
    Sinno S; Choucair M; Nasrallah M; Wadi L; Jabbour MN; Nassif S
    Int J Surg Pathol; 2016 Sep; 24(6):519-24. PubMed ID: 27006301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance.
    Sobrinho-Simões M; Máximo V; Castro IV; Fonseca E; Soares P; Garcia-Rostan G; Oliveira MC
    Int J Surg Pathol; 2005 Jan; 13(1):29-35. PubMed ID: 15735852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RET rearrangements in archival oxyphilic thyroid tumors: new insights in tumorigenesis and classification of Hürthle cell carcinomas?
    Musholt PB; Imkamp F; von Wasielewski R; Schmid KW; Musholt TJ
    Surgery; 2003 Dec; 134(6):881-9; discussion 889. PubMed ID: 14668719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid.
    Máximo V; Preto A; Crespo A; Rocha AS; Machado JC; Soares P; Sobrinho-Simões M
    BMC Cancer; 2004 Mar; 4():12. PubMed ID: 15043758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)).
    Carta C; Moretti S; Passeri L; Barbi F; Avenia N; Cavaliere A; Monacelli M; Macchiarulo A; Santeusanio F; Tartaglia M; Puxeddu E
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):105-9. PubMed ID: 16402937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two distinct thyroid tumours in a patient with Cowden syndrome carrying both a 10q23 and a mitochondrial DNA germline deletion.
    Pradella LM; Zuntini R; Magini P; Ceccarelli C; Neri I; Cerasoli S; Graziano C; Gasparre G; Turchetti D
    J Med Genet; 2011 Nov; 48(11):779-82. PubMed ID: 21926107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.
    Dahia PL; Marsh DJ; Zheng Z; Zedenius J; Komminoth P; Frisk T; Wallin G; Parsons R; Longy M; Larsson C; Eng C
    Cancer Res; 1997 Nov; 57(21):4710-3. PubMed ID: 9354427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.